☆ 4.7 Article

Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam

CLINICAL MICROBIOLOGY AND INFECTION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Public, Environmental & Occupational Health

Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures

G. Bianco et al.

JOURNAL OF HOSPITAL INFECTION (2022)

添加到收藏夹

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

添加到收藏夹

Article Infectious Diseases

Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation

Vincenzo Di Pilato et al.

Summary: This study investigated an outbreak of NDM-CPE in Tuscany, Italy, caused by ST147 K pneumoniae producing NDM-1. The clone had a complex resistome and virulome, capable of sustaining a large regional outbreak, highlighting the need for global surveillance programs to track and prevent their dissemination.

LANCET MICROBE (2022)

添加到收藏夹

Article Microbiology

Increased blaKPC Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate

Paolo Gaibani et al.

Summary: In this study, we report a case of RT-PCR-confirmed 2019 novel coronavirus (2019-nCoV) infection in a critically ill patient. The patient was diagnosed with moderate to severe infection and received treatment. The complete genome of the virus was sequenced and analyzed, revealing a close relationship between this strain and bat-derived SARS-like viruses, but a distant relationship with human coronavirus HKU1, SARS-CoV, and MERS-CoV.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Review Infectious Diseases

Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies

Ilias Karaiskos et al.

Summary: The emergence of carbapenemase resistant Gram-negative bacteria is a major public health concern. The review highlights new treatments for infections caused by carbapenemase producing Klebsiella pneumoniae, with a focus on novel antibiotics and beta-lactamase inhibitors. Approvals and developments of new antimicrobial agents show promising outcomes in combating CPKP infections, with potential for improved efficacy and safety profiles in future therapeutic strategies against multidrug-resistant K. pneumoniae.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)

添加到收藏夹

Review Infectious Diseases

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

Paolo Gaibani et al.

Summary: Multidrug resistance (MDR) is a serious global threat due to the rapid spread of MDR pathogens and limited treatment options. New beta-lactams/beta-lactamase inhibitor combinations (beta L-beta LICs) have shown promise for treating MDR Gram-negative infections. However, resistance to these novel molecules has started to emerge. This review summarizes the mechanisms of resistance to ceftazidime/avibactam, meropenem/vaborbactam, and imipenem/relebactam in MDR Gram-negative microorganisms, with a focus on antimicrobial activities and resistance traits related to novel beta L-PLICs. The detection methods for antimicrobial susceptibility testing of these molecules are also discussed.

ANTIBIOTICS-BASEL (2022)

添加到收藏夹

Article Microbiology

New Perspectives on Antimicrobial Agents: Imipenem-Relebactam

J. Nicholas O'Donnell et al.

Summary: Imipenem/cilastatin/relebactam is a novel combination medication with expanded activity against carbapenem-resistant non-Morganellaceae Enterobacterales and difficult-to-treat Pseudomonas aeruginosa. It has been approved for the treatment of certain bacterial infections when alternative treatments are limited. Further research is needed to determine its optimal role in treating highly resistant Gram-negative infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Microbiology

Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae

Sophia David et al.

Summary: Mutations in outer membrane porins act in synergy with carbapenemase enzymes to increase carbapenem resistance in Klebsiella pneumoniae. The diversity, spread and impact of different insertions in the extracellular loop 3 region of OmpK36 were characterized. The study found that different insertions resulted in varying degrees of pore constriction and resistance to antibiotics.

PLOS PATHOGENS (2022)

添加到收藏夹

Article Microbiology

KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam

Vincenzo Di Pilato et al.

Summary: This study characterized a Klebsiella pneumoniae isolate with high-level resistance to ceftazidime-avibactam due to the presence of KPC-53, a variant of KPC-3 with unique genetic features. Whole-genome sequencing revealed the presence of two copies of blaKPC-53 on different plasmids, shedding light on the mechanisms of resistance to ceftazidime-avibactam.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy

Melissa J. Martin et al.

Summary: This study conducted genomic analysis of NDM-producing carbapenem-resistant Klebsiella pneumoniae in Tuscany, Italy, finding that the isolates belonged to the high-risk clone ST-147 and shared a recent ancestor with clinical isolates from the Middle East. Additionally, it was discovered that these isolates carried a new plasmid, indicating mutations that confer resistance to multiple antibiotics.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Infectious Diseases

Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC β-lactamase mutants and the inoculum effect

Claire Amaris Hobson et al.

Summary: This study reveals that CZA-resistant KPC variants may lead to cross-resistance to cefiderocol by increasing the MICs. Additionally, cefiderocol is greatly impacted by the inoculum effect, indicating precautions should be taken when treating infections with suspected high inoculum levels.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Review Infectious Diseases

Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations

Irene Galani et al.

Summary: Multi-drug-resistant Klebsiella pneumoniae is a major concern in bacterial resistance, with reports of strains developing resistance to Ceftazidime-Avibactam during treatment. Understanding the mechanisms of resistance can help improve the efficacy of current antimicrobials and guide the design of novel therapeutic agents that can overcome resistance mechanisms.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

添加到收藏夹

Article Microbiology

Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates

Alessandra Carattoli et al.

Summary: A study conducted in a university hospital in Rome, Italy identified multiple CZA-resistant KPC-3 protein variants, including novel variants that had not been reported before. These variants showed different sensitivities and activities to antibiotics, possibly due to mutations caused by amino acid substitutions, insertions, and deletions.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Review Infectious Diseases

Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies

Stefano Di Bella et al.

Summary: Resistance to CAZ-AVI is emerging among KPC-E infections, primarily from K. pneumoniae ST258 with D179Y substitution. It poses a serious threat and requires close monitoring due to high infection rates and severity of the condition.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)

添加到收藏夹

Article Microbiology

Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae

Marco Coppi et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Infectious Diseases

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

Irene Galani et al.

EUROSURVEILLANCE (2020)

添加到收藏夹

Review Infectious Diseases

Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination

Andrea Novelli et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)

添加到收藏夹

Review Microbiology

New beta-Lactam-beta-Lactamase Inhibitor Combinations

Dafna Yahav et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

添加到收藏夹

Article Microbiology

Phenotypic, Biochemical, and Genetic Analysis of KPC-41, a KPC-3 Variant Conferring Resistance to Ceftazidime-Avibactam and Exhibiting Reduced Carbapenemase Activity

Linda Mueller et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections

Krisztina M. Papp-Wallace

EXPERT OPINION ON PHARMACOTHERAPY (2019)

添加到收藏夹

Article Infectious Diseases

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

Alessandro Cassini et al.

LANCET INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Microbiology

Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae

Dongxu Sun et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Microbiology

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

Kirk Nelson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Letter Microbiology

Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3

Romney M. Humphries et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Infectious Diseases

Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy

Costas C. Papagiannitsis et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

添加到收藏夹

Review Microbiology

Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

L. S. Tzouvelekis et al.

CLINICAL MICROBIOLOGY REVIEWS (2012)

添加到收藏夹

Article Microbiology

Functional Characterization of Tn4401, a Tn3-Based Transposon Involved in blaKPC Gene Mobilization

Gaelle Cuzon et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.